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Bovine leukosis usually
develops in organs or lymph
nodes and is not expressed
until adulthood.
Cattle with the adult
(enzootic) form of bovine
leukosis are usually 4 years of
age or older, but the disease
can occur as early as 2 years
of age.
BLV cows may be culled
because of poor milk produc-
tion that, in some instances,
results from poor appetite
and weight loss. Poor appetite
may be attributable to neo-
plastic growths in the pharyn-
geal area, which inhibit the
ability to swallow.
Other signs of the disease
vary. Affected cows may be
diagnosed as having such
problems as traumatic
reticuloperitonitis/
reticulopericarditis, abomasal
problems, and spinal cord
lesions, especially those
affecting the rear legs.
Abortions and infertility
also may occur if the uterus
or other reproductive organs
are affected.
Diagnosis and Trans-
mission
Rectal palpation is the best
diagnostic tool to locate
internal tumors if peripheral
lymph node enlargement or
exophthalmos is not ob-
served.
Using the agar gel immun-
odiffusion (AGID) test, BLV-
infected cattle can be identi-
fied by testing sera for BLV
antibodies. The virus often
remains dormant in infected
cows until they are stressed,
such as during extremely hot
or cold weather, parturition,
or illness. Clinical signs are
apparent in BLV-infected
cattle less than 1 percent of
the time. However, the
number of cows condemned
at slaughter plants is on the
rise, suggesting that the
number of infected cows is
increasing nationally.
The virus is usually
transmitted through contact
with the blood of an infected
animal. Only 0.0005 milliliter
of blood is needed for the
virus to infect the lympho-
cytes of healthy animals.
BLV can spread through
such procedures as infections,
castration, dehorning, and
rectal palpation, as well as
through insect vectors, such
as horseflies. Balling guns, or
any instrument that comes in
contact with cattle, should be
sanitized properly after each
use. Breeding by natural
service may also be a source
of infection because blood
may be transferred during
copulation.
The calves of infected dams
become infected with the
virus at birth about 5 percent
of the time.
In addition, calves fed BLV-
positive milk have a greater
risk of contracting the infec-
tion. Cows with a high virus
load and low antibody titer
may transmit infection to
their offspring, whereas cows
exhibiting a low virus load
and high antibody titer are
more likely to transfer immu-
nity to their offspring. This
immunity is only temporary,
Bovine leukosis, bovine leukemia, lymphosarcoma, and
malignant lymphoma are all names given to the retrovirus
disease caused by bovine leukosis virus (BLV) in cattle. All of
these terms refer to a neoplastic condition of tissues that
affects lymph nodes and lymphocytes. True leukemias, in
which the entire body is affected, are rare.
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2however, as it results from
colostral antibodies that last
just a few months.
To date, little evidence
exists that BLV is transmis-
sible to humans. Pasteuriza-
tion destroys the virus easily,
and it can live only a few
hours at room temperature
outside of living cells.
Families that consumed
raw milk containing the virus
were studied and found to be
free of BLV infection.
In addition, veterinarians
and others who work closely
with BLV-positive blood on a
daily basis have not been
infected.
Economic Losses
Breeders of purebreds
suffer the biggest economic
losses if their cattle are found
to be BLV-positive. Many
countries and U.S. companies
will not accept animals or
animal products infected with
BLV. Heifers or semen may be
rejected, resulting in a large
monetary loss to the breeder.
Some countries also require
embryo-producing dams to
be seronegative. The eco-
nomic impact to commercial
dairy producers includes
treatment and diagnostic
costs, reduced performance,
on-farm death losses, con-
demned carcasses, and cost of
replacements.
Prevalence in U.S.
Dairies
The number of cows in the
United States condemned at
slaughter because of lymph
node tumors
(lymphoasrcomas) tripled
between 1975 and 1990 and is
now nine times that of what
Denmark was during the
1950s (before leukosis control
and eradication programs had
begun).
It has been suggested that
less than 2 percent of infected
cows will develop lymphosar-
coma in a typical dairy
operation each year.
The total number of U.S.
animals infected with BLV
has not been determined;
however, in a study of the
upper midwest states during
the 1970s, approximately 20
percent of cows were esti-
mated to be infected.
In 1984, some states,
including Wisconsin (22.2
percent), Florida (47.7 per-
cent, and Michigan (30
percent) reported the preva-
lence of BLV-infected dairy
cattle. Beef cows had lower
infection rates, ranging from
0.12 percent to 6.7 percent.
More recent information
indicates that 89 percent of
U.S. dairy operations contain
BLV-positive cattle.
The increasing number of
condemned carcasses sug-
gests that the current manage-
ment of dairy cows is not
preventing additional BLV
infections. Although BLV is
not easily spread from animal
to animal, increasing animal
density per pen and exposure
to blood increase the risk of
transmission.
Calf management prac-
tices, such as gouge dehorn-
ing, ear tagging, and brand-
ing, can contaminate feed
areas and other facilities with
blood.
Multiple use of the same
needle during routine vacci-
nations, use of unsterilized
needles, and not changing
gloves during insemination or
pregnancy testing can also
increase the number of BLV-
positive animals.
Establishing an Elimina-
tion Program
Because no BLV vaccine is
available, establishing new
management and veterinary
practices is the key to control-
ling the disease (see Recom-
mendations for Reducing BLV
Transmission). The first step
is blood testing, which allows
BLV-positive animals to be
identified and grouped
separately.
The serologic test of
animals younger than 6
months of age may show
false-positive results because
of the presence of colostral
antibodies. Pregnant animals
should be serotested at least 6
weeks before parturition to
prevent false-negatives,
which result from immuno-
globulins shifting to colos-
trum.
Simply separating infected
animals will reduce incidence
when older BLV-positive
cows are replaced by BLV-
negative heifers.
Complete eradication
programs should be imple-
mented by dairies that sell
heifers, embryos, or semen so
they can achieve BLV-free
status for their herds. Only
one state, New York, has
certification programs to
identify BLV-free dairy herds.
Proposals for control
include:
• Identifying sick animals
through regular blood
testing.
• Establishing practices and
procedures to prevent the
transfer of blood or other
fluids from BLV-positive to
BLV-negative animals.
• Isolating infected from
noninfected animals.
• Increasing culling rates
may also help to rid the
herd of BLV-positive cows
more quickly and to reduce
exposure of healthy
animals.
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3Recommendations
for reducing BLV
transmission
• Use only single-use dispos-
able needles and palpation
sleeves and then discard.
• Thoroughly clean all
surgical instruments that
come into contact with
blood, such as those for
dehorning, castration, extra
teat removal, tagging, and
tattooing.
• Disinfect instruments
between uses.
• Reduce numbers of biting
insects
• Test all cattle entering the
herd for BLV, and isolate
them for 30 to 60 days. Test
again at the end of the
isolation period.
• Implement annual testing
for all animals. A 3- to 4-
month testing interval is
preferred but may be
impractical.
• Use BLV-negative bulls or
semen for all breedings.
• Do not use colostrum or
milk from BLV-positive
cows. Feed calves milk
replacer or pasteurized
milk when BLV-free milk is
not available.
• Store intravenous tubing
and needles in a disinfec-
tant solution, such as
chlorhexidine.
• Cold sterilize calf delivery
equipment between uses.
• Do not use BLV-positive
cows as recipients for
embryo transfer. If a highly
valuable donor is tested
positive, implant embryos
in BLV-negative cows and
test the offspring of the
donor to be sure they are
BLV-free.
• Remove extra teats, insert
ear tags, and dehorn while
calves are housed indi-
vidually.
• Use bloodless dehorning
methods, such as electric,
hot iron, or caustic paste.
• Clean feed and water
containers regularly to
reduce blood contamina-
tion.
• Perform all veterinary
procedures on BLV-positive
cows last.
• Milk all BLV-positive cows
last.
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